Clinical Trial Update: Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

View source ↗

Summary

A planned clinical trial to evaluate plasma host-microbe proteomics as a predictor of complications in patients with high-risk febrile neutropenia; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Snippet

Sponsor: Instituto de Investigación Biomédica de Salamanca | Conditions: Febrile Neutropenia | Status: NOT_YET_RECRUITING